Features of durable response and treatment efficacy for capecitabine monotherapy in advanced breast cancer: real-world evidence from a large single-centre cohort.
S ThijssenHans P M W WildiersKevin PunieBenoit BeuselinckP ClementC RemmerieP BertelootSileny N HanEls Van NieuwenhuysenToon Van GorpIgnace VergoteAnn SmeetsInes NevelsteenGiuseppe FlorisCaroline WeltensJohan MentenH JanssenA LaenenPatrick NevenPublished in: Journal of cancer research and clinical oncology (2021)
Our data display relevant clinical-pathological features associated with DR and TTP in patients receiving capecitabine monotherapy for MBC.
Keyphrases
- combination therapy
- phase ii study
- open label
- locally advanced
- phase iii
- metastatic breast cancer
- metastatic colorectal cancer
- electronic health record
- randomized controlled trial
- big data
- squamous cell carcinoma
- rectal cancer
- radiation therapy
- study protocol
- deep learning
- young adults
- smoking cessation
- breast cancer risk
- placebo controlled